Perfil
Vic Myer is currently the Director at KromaTid, Inc. and an Advisor at Atlas Venture Advisors, Inc. Previously, he held the position of Executive Director at Novartis AG from 2004 to 2015.
He also served as the Director, Head-Developmental & Molecular Pathways at Biomedical Research, Inc. Additionally, Dr. Myer was the Chief Technology Officer at Editas Medicine, Inc. from 2015 to 2019.
He was a Board Member at Standards Coordinating Body from 2018 to 2020.
Dr. Myer is the President & Chief Scientific Officer at Chroma Medicine, Inc. Dr. Myer obtained a doctorate degree from Yale University in 1995 and an undergraduate degree from Cornell University in 1989.
Cargos activos de Vic Myer
| Empresas | Cargo | Inicio |
|---|---|---|
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Miembro de la Junta | 21/09/2020 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultor / Asesor | - |
Antiguos cargos conocidos de Vic Myer.
| Empresas | Cargo | Fin |
|---|---|---|
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials. | Director/Miembro de la Junta | 01/07/2020 |
| EDITAS MEDICINE, INC. | Director Técnico/Científico/I+D | 07/10/2019 |
| NOVARTIS AG | Director/Miembro de la Junta | 30/04/2015 |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Presidente | - |
Biomedical Research, Inc.
Biomedical Research, Inc. BiotechnologyHealth Technology Provides biomedical research services | Corporate Officer/Principal | - |
Formación de Vic Myer.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 9 |
|---|---|
KromaTid, Inc.
KromaTid, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biomedical Research, Inc.
Biomedical Research, Inc. BiotechnologyHealth Technology Provides biomedical research services | Health Technology |
Editas Medicine, Inc.
Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
Standards Coordinating Body
Standards Coordinating Body The Standards Coordinating Body is a nonprofit organization focused on accelerating the development, awareness, and implementation of standards and best practices in regenerative medicine, including gene, cell, and advanced therapies. The private company is based in Gaithersburg, MD. It engages stakeholders such as government agencies, researchers, manufacturers, clinicians, and regulators to identify, prioritize, and advance standards that improve the safety, quality, efficacy, and availability of regenerative medicine products. The organization facilitates collaborative project working groups that develop feasibility studies, standards drafts, white papers, and coordinate data generation activities in areas like cell-based drug discovery, cell therapy, gene therapy, and tissue engineering. It offers specialized training programs on FDA-recognized ISO cell counting standards, including online and in-person courses, and provides resources such as an interactive database for exploring current and developing standards and educational materials. | |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomic medicines | Health Technology |
- Bolsa de valores
- Insiders
- Vic Myer
















